The Board of Directors of CSPC Innovation Pharmaceutical Co., Ltd. has authorized a buyback plan on September 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.01 CNY | -2.47% | -8.80% | +4.89% |
Apr. 22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.89% | 6.23B | |
+16.86% | 8.43B | |
+3.57% | 7.49B | |
-5.23% | 3.75B | |
-6.58% | 3.75B | |
-3.55% | 1.33B | |
-28.64% | 1.09B | |
+18.12% | 1.02B | |
-8.60% | 933M | |
-17.08% | 801M |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- CSPC Innovation Pharmaceutical Co., Ltd. authorizes a Buyback Plan.